Navigation Links
Chief Medical Officer Summit for Biotechs Goes West
Date:6/17/2013

New York, NY (PRWEB) June 17, 2013

With the huge success of CMO East, we are thrilled to announce the launch of the Chief Medical Officer Summit for Emerging Life Science Companies on the West Coast! CMO West will take place in San Francisco on November 4-5, 2013 at the Marines Memorial Club & Hotel.

For the first time, West Coast Chief Medical Officers at biotechs have their own conference, thanks to the idea from Dr. Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive Director of The Conference Forum, the event organizer said, “We are grateful to Dr. Stoner’s idea for the conference and her insights into the unique challenges CMOs face every day at small to mid-size biotechs.”

The Chief Medical Officer Summit West is dedicated to accomplishing two goals:

1. To provide a forum to address the unique needs of Emerging Life Science Chief Medical Officers in de-risking drug development, selecting and managing CROs, leveraging capital to manage all R&D functions with limited resources, working more successfully with investors and strategizing for appropriate exits in the current environment.

2. To create a network of Life Science CMOs to form a community that can shares ideas, solutions and support.

Boston attendee Dominic J.F. Tong, MD said of the program, "It is a pleasure to have attended a historic meeting [of] the outstanding inaugural Chief Medical Officer Summit."

CMO West speaker Santosh Vetticaden, PhD, MD, CMO, SVP, Mast Therapeutics, Inc., said, "I found the East Coast meeting extremely useful since it was designed exclusively to addressing CMO interests. The opportunity to network with my peers at this event was invaluable since, barring this meeting, interactions I have with my peers tend to be at scientific meetings where the focus is the scientific meeting and not the CMO peer interactions."

About The Conference Forum:
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

The Speaking Faculty: Full Biographies Available Here

Srinivas Akkaraju, MD, PhD, General Partner, Sofinnova Ventures
Lee Allen, MD, PhD, CMO, Spectrum Pharmaceuticals
Zoran Antonijevic, Senior Director, Strategic Consulting and Adaptive Implementation, Cytel Inc.
Mohammad Azab, MD, MBA, CMO, Astex Pharmaceuticals
Jodi Black, PhD, Deputy Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, NIH
Jill Carroll, Senior Associate, SR One
Farah Champsi, MBA, Managing Director, Alta Partners
Adam Craig, MD, PhD MBA, EVP, Development & CMO, Sunesis Pharmaceuticals, Inc.
Howard Dittrich, MD, CMO, Sorbent Therapeutics
Sheila Gujrathi, MD, CMO, Receptos, Inc.
Barry Hafkin, MD, CMO, Affinium Pharmaceuticals
Laurie Halloran, BSN, MS, President & CEO, Halloran Consulting Group, Inc.
Julie Hambleton, MD, SVP & CMO, Five Prime Therapeutics
M. Scott Harris, MD, CMO / Principal / Clinical Professor of Medicine, Avaxia Biologics, Inc. / Middleburg Consultants / Georgetown University School of Medicine
Rekha Hemrajani, MBA, Vice President, Head of Licensing & M&A, Onyx Pharmaceuticals
Jan Johansson, MD, PhD, SVP Medical Affairs, Resverlogix
Jeff Jonker, Former Chief Business Officer, Satori Pharmaceuticals
Lori Kunkel, MD, CMO, PCYC
Jeffery Loutit, MBChB, CMO, Rempex Pharmaceuticals
Jonathan MacQuitty, PhD, MBA, Partner, Abingworth
Tyler Martin, MD, Former President, CMO & Director, Dynavax Technologies
Nestor Molfino, MD, CMO, KaloBios
Pamela Palmer, MD, PhD, CMO, AcelRx Pharmaceuticals, Inc.
Hemai Parthasarathy, PhD, Scientific Director, Breakout Labs, The Thiel Foundation
Carol Sands, Managing General Partner / Founder, The Halo Funds / The Angels’ Forum
Tracy Saxton, PhD, Associate, SV Life Sciences
Oscar Segurado, MD, PhD, CMO, Crescendo Bioscience
Jeffrey Sherman, MD, FACP, CMO & EVP, Development, Manufacturing and Regulatory Affairs, Horizon Pharma
Stephen Shrewsbury, MD, MBChB, MRCGP, FCCP, FACAAI, FFPM, FAAAAI, SVP, Clinical Development & CMO, Aquinox Pharmaceuticals
Michael Sweeney, MD, CMO & VP of R&D, Depomed
Frank Torti, MD, Principal, NEA
Santosh Vetticaden, MD, PhD, CMO, SVP, Mast Therapeutics, Inc.
Samuel Wu, MD, PhD, Managing Director, MedImmune Ventures

Read the full story at http://www.prweb.com/releases/2013/6/prweb10826992.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
5. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
6. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
7. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
8. Codexis Names Wes Bolsen VP and Chief Marketing Officer
9. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
10. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
11. GenVec President and Chief Executive Officer Announces Retirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 10, 2016  The Maryland House of Delegates and ... that University of Maryland School of Medicine Dean ... of Maryland Medical System President and CEO Robert ... the highest honor given to the public by the ... Dean Reece and Mr. Chrencik for their contributions ...
(Date:2/10/2016)... York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has ... develop new vaccines and immunotherapies for infectious diseases and cancer. , ...
(Date:2/10/2016)...  Matchbook, Inc., a company specializing in procurement ... announced today the appointment of Jim Shuman ... nearly 25 years of experience in supply chain, ... two decades in executive level roles as the ... and, most recently headed global logistics and procurement ...
(Date:2/10/2016)... , ... February 10, 2016 , ... LATHAM, NEW YORK... ... the SPIE Photonics West conference in San Francisco’s Moscone Center from February ... the same venue. , These latest InGaAs PIN diode standard packages feature a ...
Breaking Biology Technology:
(Date:1/28/2016)... -- Synaptics (NASDAQ: SYNA ), a leading developer of human ... December 31, 2015. --> --> ... 2 percent compared to the comparable quarter last year to $470.5 ... $35.0 million, or $0.93 per diluted share. ... quarter of fiscal 2016 grew 9 percent over the prior year ...
(Date:1/22/2016)... , Jan. 22, 2016 ... the addition of the "Global Biometrics ... to their offering. --> ... the "Global Biometrics Market in Retail ... --> Research and Markets ...
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
Breaking Biology News(10 mins):